Repligen Reports Fourth Quarter and Year 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
Repligen (RGEN) Reports In-Line Q4 EPS
February 25, 2016 7:32 AM ESTRepligen (NASDAQ: RGEN) reported Q4 EPS of $0.07, in-line with the analyst estimate of $0.07. Revenue for the quarter came in at $21.4 million versus the consensus estimate of $19.84 million.
Tony J. Hunt, President and Chief Executive Officer said, 2015 was a great year for... More



